Key result
Elevated Lp(a) is linked to higher CAD and peripheral vascular disease risk across Asian populations.
Why the study?
The relationship of elevated lipoprotein(a) to cardiovascular disease is well characterized in European populations but data are lacking in the Asian region.
Does elevated Lipoprotein(a) increase the risk of cardiovascular disease in Asian populations?
Does elevated Lipoprotein(a) increase the risk of cardiovascular disease in Asian populations?
Answers are grounded in this paper and cite their sources.
This review confirms that elevated Lipoprotein(a) is a robust risk factor for cardiovascular disease in Asian populations, though population-specific thresholds for risk assessment may be required given the ethnic variations in normal Lp(a) distributions.
Elevated lipoprotein (a) (Lp[a]) is becoming increasingly recognized as a cardiovascular disease risk factor. The relationship of Lp(a) to cardiovascular disease is well characterized in European populations; however, data are lacking in the Asian region. In this scoping review, we aimed to characterize the distribution and prevalence of elevated Lp(a) in the Asian region and its relationship to coronary artery disease, cerebrovascular disease, and peripheral vascular disease. Thirty-one Asian studies met the inclusion criteria and were compared with 6 representative European studies. The greatest representation was in Chinese populations, with much less representation of Japanese, Thai, Indian, and other groups. Levels of Lp(a) in healthy Asian populations were generally lower than in Europid (Caucasian) populations; however, these levels remain lower than those reported in European literature. Within Asian populations, elevated Lp(a) was universally associated with increased risk of coronary artery disease and peripheral vascular disease. The relationship with stroke was less clear.
No takes yet. Share an insight, caveat, or question.
D'Amore et al. (2026) conducted a review in Cardiovascular disease (coronary artery disease, cerebrovascular disease, peripheral vascular disease) and healthy individuals. Elevated Lipoprotein(a) vs. Normal or low Lipoprotein(a) was evaluated on Cardiovascular disease (coronary artery disease, cerebrovascular disease, and peripheral vascular disease). Elevated Lipoprotein(a) was universally associated with increased risk of coronary artery disease and peripheral vascular disease across diverse Asian populations.
Synapse has enriched 10 related papers. Consider them for comparative context: